NEW YORK--(BUSINESS WIRE)--Xalud Therapeutics, a clinical-stage biotechnology company developing DNA-delivered therapeutics, today announced the first patient dosed in a Phase 2a clinical trial of its ...
Facet joints are essential for guiding spinal movement and sharing loads, but injury, degeneration, or arthritis can make them a major pain source. Advances in imaging and targeted therapies are ...
NORWALK, Conn.--(BUSINESS WIRE)--Premia Spine, a medical technology company changing the way debilitating chronic leg and back pain is treated, today announced publication of one-year outcomes from ...